March 20, 2020 10:01 AM EDTUpdated March 25, 06:21 AM

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

John Carroll

Editor & Founder

Pratik Shah and Aseem Ansari have snared a $45 million launch round for Design Therapeutics, a San Diego-based outfit that is focused on degenerative diseases …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

John Carroll

Editor & Founder

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs

China startup injects CRISPR therapy into the brain for the first time

Trodelvy and Keytruda combo succeeds in Phase 3 breast cancer study

Roivant brings rare disease program closer as Immunovant CEO retires

FDA plans to ban pharma employees from serving on adcomms. The impact will be limited

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

A key play­er be­hind 2 multi­bil­lion-dol­lar biotech M&A deals is back in the start­up busi­ness

Editor & Founder

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business